ArticleTranslational lung cancer research2025

Ivonescimab plus chemotherapy in advanced or metastatic non‑squamous non‑small cell lung cancer with EGFR variant in China: a cost-effectiveness analysis.

Rong Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.